Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis

Documenti analoghi

• Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
  di: Romão, Vasco Crispim, et al.
  Pubblicazione: (2013)
• Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
  di: Romão, Vasco C., et al.
  Pubblicazione: (2017)
• TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
  di: Canhão, Helena, et al.
  Pubblicazione: (2012)
• Predictors of response and anti-TNF drugs comparative efficacy
  di: Canhão, Helena, et al.
  Pubblicazione: (2011)
• B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis
  di: Moura, Rita A., et al.
  Pubblicazione: (2017)